Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:741-745

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumimoto, T.
Right arrow Articles by Kangawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumimoto, T.
Right arrow Articles by Kangawa, K.

(Hypertension. 1997;30:741.)
© 1997 American Heart Association, Inc.


Articles

Plasma Adrenomedullin Concentrations and Cardiac and Arterial Hypertrophy in Hypertension

Takumi Sumimoto; Toshio Nishikimi; Mikio Mukai; Keisuke Matsuzaki; Eiki Murakami; Shuichi Takishita; Atsuro Miyata; Hisayuki Matsuo; Kenji Kangawa

From the Hypertension Center (T.S., M.M., K.M., E.M.), Kinki Central Hospital, Itami, and the Research Institute (T.N, A.M., H.M., K.K.) and Department of Medicine (S.T.), National Cardiovascular Center, Osaka, Japan.

Correspondence to Toshio Nishikimi, MD, Division of Hypertension, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita, Osaka 565, Japan. E-mail nishikim{at}jsc.ri.ncvc.go.jp

Abstract It has been reported that plasma concentrations of adrenomedullin (AM), a novel vasodilator peptide, are higher in patients with essential hypertension than those in normotensive subjects. To clarify the clinical significance of increased levels of AM in patients with essential hypertension, in this study we examined the relationship between plasma concentrations of AM and the structure of the left ventricle or carotid artery. Plasma AM concentrations; renin activity; and norepinephrine, epinephrine, and creatinine concentrations in 50 patients with untreated essential hypertension without renal dysfunction and heart failure were measured. We also measured the mean wall thickness of the left ventricle and left ventricular mass index by M-mode echocardiography and intimal-medial thickness and arterial distensibility of the carotid artery by ultrasonography. Hypertensive patients were divided into two groups: hypertensives with and those without left ventricular hypertrophy. Plasma AM concentrations in hypertensive patients with left ventricular hypertrophy were significantly higher than in hypertensive patients without left ventricular hypertrophy (7.87±2.70 vs 5.74±1.65 fmol/mL, P<.01). In all hypertensive patients, plasma AM concentrations were not correlated with blood pressure, plasma renin activity, plasma norepinephrine, plasma epinephrine, or plasma creatinine concentration. Plasma AM concentrations were positively correlated with left ventricular mass index or mean wall thickness (r=.37, P=.009; r=.40, P=.004, respectively) and inversely correlated with carotid artery distensibility (r=-.33, P=.02), whereas plasma AM concentrations were not correlated with intimal-medial thickness. These results suggest that the observed elevation of plasma AM in patients with essential hypertension with normal renal function may be partly related to cardiac hypertrophy and decreased carotid artery distensibility.


Key Words: left ventricular hypertrophy • carotid artery • hypertension • adrenomedullin




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Mak, B. M. Y. Cheung, C. C. Mok, R. Leung, and C. S. Lau
Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus
Rheumatology, October 1, 2006; 45(10): 1266 - 1272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhao, D. Bell, L. R. Smith, L. Zhao, A. B. Devine, E. M. McHenry, D. P. Nicholls, and B. J. McDermott
Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1269 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Bell, Y.-Y. Zhao, E. J. Kelso, E. M. McHenry, L. M. Rush, V. M. Lamont, D. P. Nicholls, and B. J. McDermott
Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H904 - H914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. M. Taylor, J. R. Baker, and W. K. Samson
Brain-derived adrenomedullin controls blood volume through the regulation of arginine vasopressin production and release
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1203 - R1210.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Katayama, H. Nakashima, Y. Honda, S. Suzuki, and K. Yano
Relationship Between Adrenomedullin and Left-Ventricular Systolic Function and Mortality in Acute Myocardial Infarction
Angiology, January 1, 2005; 56(1): 35 - 42.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
S. D. Brain and A. D. Grant
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Physiol Rev, July 1, 2004; 84(3): 903 - 934.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Tambara, M Fujita, N Nagaya, S Miyamoto, A Iwakura, K Doi, G Sakaguchi, K Nishimura, K Kangawa, and M Komeda
Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling
Heart, March 1, 2002; 87(3): 242 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Terata, H. Miura, Y. Liu, F. Loberiza, and D. D. Gutterman
Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K+ channels
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2620 - H2626.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. W. Troughton, L. K. Lewis, T. G. Yandle, A. M. Richards, and M. G. Nicholls
Hemodynamic, Hormone, and Urinary Effects of Adrenomedullin Infusion in Essential Hypertension
Hypertension, October 1, 2000; 36(4): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Piquard, A. Charloux, B. Mettauer, E. Epailly, E. Lonsdorfer, S. Popescu, J. Lonsdorfer, and B. Geny
Exercise-Induced Increase in Circulating Adrenomedullin Is Related to Mean Blood Pressure in Heart Transplant Recipients
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2828 - 2831.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Tsuruda, J. Kato, K. Kitamura, T. Imamura, Y. Koiwaya, K. Kangawa, I. Komuro, Y. Yazaki, and T. Eto
Enhanced Adrenomedullin Production by Mechanical Stretching in Cultured Rat Cardiomyocytes
Hypertension, June 1, 2000; 35(6): 1210 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Yoshihara, T. Nishikimi, T. Horio, C. Yutani, N. Nagaya, H. Matsuo, T. Ohe, and K. Kangawa
Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H633 - H642.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Geny, G. Brandenberger, J. Lonsdorfer, N. Chakfe, P. Haberey, and F. Piquard
Circulating adrenomedullin is increased after heart transplantation
Cardiovasc Res, March 1, 1999; 41(3): 731 - 736.
[Abstract] [Full Text] [PDF]